AXT Inc (AXTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth …

GuruFocus News

Fri, February 20, 2026 at 2:03 PM GMT+9 4 min read

In this article:

AXTI

+1.15%

This article first appeared on GuruFocus.

**Revenue:** $23.0 million in Q4 2025, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024.

**Indium Phosphide Revenue:** $8.0 million, primarily from data center applications.

**Gallium Arsenide Revenue:** $7.0 million.

**Germanium Substrates Revenue:** $231,000.

**Consolidated Raw Material Joint Venture Revenue:** $7.6 million.

**Non-GAAP Gross Margin:** 21.5% in Q4 2025, compared to 22.6% in Q3 2025 and 18.0% in Q4 2024.

**GAAP Gross Margin:** 20.9% in Q4 2025, compared to 22.3% in Q3 2025 and 17.6% in Q4 2024.

**Non-GAAP Operating Expense:** $7.8 million in Q4 2025, compared to $6.5 million in Q3 2025 and $9.8 million in Q4 2024.

**GAAP Operating Expense:** $8.8 million in Q4 2025, compared to $7.3 million in Q3 2025 and $10.6 million in Q4 2024.

**Non-GAAP Operating Loss:** $2.6 million in Q4 2025, compared to $384,000 in Q3 2025 and $5.4 million in Q4 2024.

**GAAP Operating Loss:** $3.8 million in Q4 2025, compared to $1.1 million in Q3 2025 and $6.2 million in Q4 2024.

**Non-GAAP Net Loss:** $2.6 million or $0.06 per share in Q4 2025, compared to $1.2 million or $0.02 per share in Q3 2025.

**GAAP Net Loss:** $3.6 million or $0.08 per share in Q4 2025, compared to $1.9 million or $0.04 per share in Q3 2025.

**Cash, Cash Equivalents, and Investments:** Increased by $97.2 million to $128.4 million as of December 31, 2025.

**Depreciation and Amortization:** $2.3 million in Q4 2025.

**Stock Compensation:** $1.3 million in Q4 2025.

**Net Inventory:** Increased by approximately $4 million to $81.7 million in Q4 2025.

Warning! GuruFocus has detected 10 Warning Signs with AXTI.

Is AXTI fairly valued? Test your thesis with our free DCF calculator.

Release Date: February 19, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

AXT Inc (NASDAQ:AXTI) reported a significant increase in cash, cash equivalents, and investments, rising to $128.4 million due to a successful public offering.

The company has seen a strong demand for indium phosphide wafers, with a backlog reaching over $60 million, indicating robust future sales potential.

AXT Inc (NASDAQ:AXTI) is expanding its customer base, particularly in the optical space, including Tier 1 laser manufacturers and optical transceiver module makers.

The company has increased its indium phosphide wafer capacity by 25% and plans to double it by the end of 2026, positioning itself well to meet growing demand.

AXT Inc (NASDAQ:AXTI) is actively engaging in discussions for long-term supply agreements with customers, providing better visibility into future demand and stability.

 






Story Continues  

Negative Points

Revenue for the fourth quarter of 2025 decreased to $23.0 million from $28.0 million in the previous quarter, indicating a decline in sales.

The company reported a non-GAAP net loss of $2.6 million for Q4 2025, which is an increase from the previous quarter's loss of $1.2 million.

AXT Inc (NASDAQ:AXTI) faced challenges with export permits, which limited their ability to meet demand and affected revenue potential.

Operating expenses increased in Q4 2025 to $7.8 million from $6.5 million in Q3 2025, reflecting higher costs.

The geopolitical environment and lack of transparency in the export permit process pose ongoing risks to the company's operations and growth potential.

Q & A Highlights

Q: Can you clarify the revenue guidance for Q1 2026 and the potential upside? A: Gary Fischer, CFO, stated they are confident in achieving $26 million in revenue for Q1 2026, based on current permits. There is potential for upside if additional permits are received, but the timing and success of obtaining these permits are unpredictable.

Q: What insights can you provide about the export permit process and any denials? A: Timothy Bettles, VP of Business Development, explained that the permit process lacks transparency and has become more variable. Some permits have been denied but with instructions to resubmit with more information, indicating a potential for approval upon resubmission.

Q: How is the backlog evolving, and how far out are customers placing orders? A: Morris Young, CEO, noted that the backlog for indium phosphide wafers has reached over $60 million, with customers placing longer-term orders due to increasing demand. Timothy Bettles added that forecasts extend beyond 2030, with customers providing minimum demand requirements for the next two to three years.

Q: What are the plans for capacity expansion, and what is the expected capital expenditure? A: Morris Young stated that they plan to double capacity by the end of 2026, with an estimated capital expenditure of $30 million. Beyond 2026, they are considering further doubling capacity, which could require $100 million to $150 million, depending on whether they pursue a greenfield expansion.

Q: How is AXT engaging with Tier 1 customers and planning for 6-inch indium phosphide wafers? A: Timothy Bettles mentioned that AXT is gaining traction with Tier 1 customers, securing design-ins and qualifications. They are expanding capacity for 6-inch wafers, driven by customer demand, and are evaluating how to scale this alongside 3-inch and 4-inch wafers.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Terms and Privacy Policy

Privacy Dashboard

More Info